Prostaglandin-E Synthases
Medicine & Life Sciences
100%
Bone Marrow Cells
Medicine & Life Sciences
79%
Granulation Tissue
Medicine & Life Sciences
78%
Vascular Endothelial Growth Factor A
Medicine & Life Sciences
72%
Lymphangiogenesis
Medicine & Life Sciences
69%
Receptors, Prostaglandin E, EP3 Subtype
Medicine & Life Sciences
64%
Calcitonin Gene-Related Peptide
Medicine & Life Sciences
60%
Stomach Ulcer
Medicine & Life Sciences
57%
Takamatsu, R. ,
Higuchi, K. ,
Suzuki, T. &
Muramatsu, D. ,
4月 2022 ,
In: IEEJ Transactions on Electrical and Electronic Engineering. 17 ,
4 ,
p. 614-616 3 p. 研究成果: Letter › 査読
Electric properties
100%
Blood
86%
Coagulation
41%
Medical applications
35%
Permittivity
31%
Sekiya, S. ,
Suzuki, T. ,
Tanaka, R. ,
Harigai, S. ,
Shimono, K. ,
Ohura, S. ,
Hashiba, H. &
Shikamura, Y. ,
8月 2022 ,
In: Biological and Pharmaceutical Bulletin. 45 ,
8 ,
p. 1091-1100 10 p. 研究成果: Article › 査読
Glycemic
100%
Pharmacists
84%
Hemoglobin
79%
Type 2 Diabetes Mellitus
64%
Hemoglobins
34%
Kawano, Y. ,
Nagata, M. ,
Nakamura, S. ,
Akagi, Y. ,
Suzuki, T. ,
Tsukada, E. ,
Hoshiko, M. ,
Kujirai, A. ,
Nakamatsu, S. ,
Nishikawa, T. ,
Enomoto, A. ,
Negishi, K. ,
Shimada, S. ,
Aoyama, T. &
Mano, Y. ,
5月 2021 ,
In: Biological and Pharmaceutical Bulletin. 44 ,
5 ,
p. 611-619 9 p. 研究成果: Article › 査読
Anticoagulant Agent
100%
Anticoagulants
72%
Antihypertensive
61%
Telmisartan
60%
Warfarin
52%
Uyeda, A. ,
Quan, L. ,
Kato, Y. ,
Muramatsu, N. ,
Tanabe, S. ,
Sakai, K. ,
Ichinohe, N. ,
Kawahara, Y. ,
Suzuki, T. &
Muramatsu, R. ,
11月 2021 ,
In: GLIA. 69 ,
11 ,
p. 2591-2604 14 p. 研究成果: Article › 査読
dimethylargininase
100%
Remyelination
81%
Oligodendroglia
67%
Central Nervous System
45%
Demyelinating Diseases
21%
Sato, E. ,
Umezawa, M. ,
Miyajima, A. ,
Koishi, N. ,
Kanaya, A. ,
Yamanaka, A. ,
Fujimoto, M. ,
Ishii, Y. ,
Saito, A. ,
Inoue, S. ,
Mano, Y. ,
Suzuki, T. ,
Ozeki, R. ,
Ishii, N. &
Komoda, M. ,
2月 2021 ,
In: Journal of Cutaneous Immunology and Allergy. 4 ,
1 ,
p. 4-12 9 p. 研究成果: Article › 査読
phenothrin
100%
Pediculus
76%
Ivermectin
68%
Japan
41%
Safety
29%